Market Size of Acne Therapeutics Industry
Study Period | 2021 - 2029 |
Market Size (2024) | USD 8.64 Billion |
Market Size (2029) | USD 10.98 Billion |
CAGR (2024 - 2029) | 4.89 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Acne Therapeutics Market Analysis
The Acne Therapeutics Market size is estimated at USD 8.64 billion in 2024, and is expected to reach USD 10.98 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).
The key factors propelling the growth of the acne therapeutics market are increasing sedentary lifestyles, the rise in disposable incomes of consumers, rising awareness about upcoming trends in acne treatments, and the high prevalence of acne globally.
Acne is the most common skin condition affecting late adolescents worldwide. Acne vulgaris is a common heath problem affecting adolescents, with a considerable impact on their quality of life. For instance, the data published by ClickPharmacy in May 2022 reported that 34% of UK adults have suffered from acne at some point in their lives. The same source mentioned that 6.1% of men were suffering from acne compared to 2.5% of women in 2022. Also, according to a report published by the Journal of Clinical Medicine in June 2023, the prevalence of acne among adolescents is about 80% worldwide; however, moderate to severe acne accounts for 20% of all acne sufferers. Adult acne is an increasing problem and is currently estimated to affect 40% of the population. Thus, the rising incidence of acne will lead to increased adoption of acne therapeutics, thereby driving the market's growth.
Furthermore, in September 2023, CeraVe organized an awareness campaign for its new Clear It Up Like a Derm campaign, which helped educate consumers on preventing and treating acne. Such initiatives provide insight into the upcoming treatments for acne. These campaigns are expected to boost the growth of the market during the forecast period.
Thus, the high prevalence of acne among the global population and the rise in awareness of acne treatments are expected to drive the market during the forecast period. However, safety issues related to acne products and the entry of generics into the acne market are expected to hinder market growth.
Acne Therapeutics Industry Segmentation
As per the scope of the report, acne is a chronic inflammatory skin disease commonly affecting adolescent and adult populations. Abnormal hormone production is found to be the key causative factor. Acne therapeutics include several prescriptions and over-the-counter medicines, such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.
The acne therapeutics market is segmented by treatment, route of administration, and geography. The treatment segment is differentiated into therapeutics and other treatments. The route of administration is segmented into oral and topical. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.
By Treatment | |||||||
| |||||||
Other Treatments |
By Route of Administration | |
Oral | |
Topical |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Acne Therapeutics Market Size Summary
The acne therapeutics market is poised for significant growth over the forecast period, driven by increasing sedentary lifestyles, rising disposable incomes, and heightened awareness of acne treatment options. The market's expansion is further supported by the high prevalence of acne, particularly among adolescents, which underscores the demand for effective therapeutic solutions. The post-pandemic recovery, marked by increased patient visits to dermatology clinics, is expected to bolster market growth. Key players in the industry are actively engaging in product development and digital campaigns to educate consumers about new treatments, such as Galderma's "Me Being Me" campaign for Aklief. Despite challenges such as safety concerns and the entry of generics, the market is expected to thrive, with retinoids playing a pivotal role due to their effectiveness in treating and maintaining clear skin.
North America is anticipated to hold a significant share of the acne therapeutics market, driven by the presence of major market players and a high burden of acne in the region. The frequent product launches and approvals, such as Cutera's AviClear and Sun Pharmaceuticals' Winlevi, are expected to propel market growth. The competitive landscape is characterized by the presence of both major and local players, with companies like Abbvie Inc., Johnson & Johnson, and L'Oréal S.A. actively developing novel products and technologies. Collaborative efforts and strategic expansions, such as Sun Pharmaceuticals' territory expansion in Mexico, further highlight the dynamic nature of the market. Overall, the combination of innovative product offerings, strategic partnerships, and a growing understanding of acne treatment is set to drive the market forward.
Acne Therapeutics Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Sedentary Lifestyles and Unhealthy Food Habits
-
1.2.2 Increasing Awareness About Current and Upcoming Acne Treatments
-
1.2.3 High Global Acne Prevalence
-
-
1.3 Market Restraints
-
1.3.1 Safety Issues Regarding the Products
-
1.3.2 Entry of Generics in the Market
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Treatment
-
2.1.1 Therapeutics
-
2.1.1.1 Retinoid
-
2.1.1.2 Antibiotics
-
2.1.1.3 Hormonal Agents
-
2.1.1.4 Anti-inflammatory
-
2.1.1.5 Other Therapeutics
-
-
2.1.2 Other Treatments
-
-
2.2 By Route of Administration
-
2.2.1 Oral
-
2.2.2 Topical
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Acne Therapeutics Market Size FAQs
How big is the Acne Therapeutics Market?
The Acne Therapeutics Market size is expected to reach USD 8.64 billion in 2024 and grow at a CAGR of 4.89% to reach USD 10.98 billion by 2029.
What is the current Acne Therapeutics Market size?
In 2024, the Acne Therapeutics Market size is expected to reach USD 8.64 billion.